MAPT and Alzheimer disease: Lately it was reported that Impaired insulin sensitivity is linked to adverse changes in plasma level of AD-related biomarkers (neurofilament light chain, glial fibrillary acidic protein, Aβ 42/40, and phosphorylated tau (p-tau) 181 and 231).